Treatment with anti-TGF-β antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-β signaling

被引:88
作者
Fukasawa, H
Yamamoto, T
Suzuki, H
Togawa, A
Ohashi, N
Fujigaki, Y
Uchida, C
Aoki, M
Hosono, M
Kitagawa, M
Hishida, A
机构
[1] Hamamatsu Univ Sch Med, Dept Med 1, Hamamatsu, Shizuoka 4313192, Japan
[2] Hamamatsu Univ Sch Med, Dept Biochem, Hamamatsu, Shizuoka 4313192, Japan
[3] Japan Tobacco Inc, Pharmaceut Frontier Res Labs, Kanagawa, Japan
关键词
Transforming growth factor-beta (TGF-beta); anti-TGF-beta antibody (T); renal fibrosis; Smad; Smad-binding element (SBE); chronic progressive glomerulonephritis;
D O I
10.1111/j.1523-1755.2004.00393.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Although short-term treatment with antitransforming growth factor-beta (TGF-beta) antibody (alphaT) has been shown to prevent early glomerular lesions, its long-term effects and molecular mechanisms, including intracellular signaling, remain poorly understood. We examined whether a T treatment induces prevention of renal insufficiency and fibrosis, and affects the TGF-beta/Smad signaling pathway in rats with chronic progressive anti-thymocyte serum (ATS) nephritis induced by repeated ATS injections on days 0 and 7. Methods. Nephritic and non-nephritic rats were treated with either a T or control immunoglobulin (Ig) G twice weekly for 4 weeks from days 7 to 35 (each group, N = 21). Renal lesions and cortical expression of TGF-beta1, TGF-beta2, TGF-beta3, type II TGF-beta receptor (TbetaRII), Smads, type I collagen, and plasminogen activator inhibitor-1 were examined by immunohistochemistry, Western blot, and/or real-time reverse transcription polymerase chain reaction (RT-PCR). The binding of Smad3 in renal cortical cell nuclei to the Smad-binding element (SBE) was investigated by the electrophoretic mobility shift assay. Results. Nephritic rats developed heavy proteinuria, renal insufficiency, and increased extracellular matrix deposition resulting in renal fibrosis. Cortical expression levels of TGF-beta1, TGF-beta2, TbetaRII, and Smad2, but not TGF-beta3, Smad3, and Smad4 were increased. Expression and preferential localization of phosphorylated Smad2/3 in the glomerular and tubular cell nuclei, and Smad3-SBE complex-forming activity were also increased. Four-week alphaT treatment resulted in marked amelioration of chronic progressive ATS nephritis at 8 weeks. Conclusion. In chronic progressive ATS nephritis, the TGF-beta/Smad signaling was up-regulated. TGF-beta blockade by alphaT suppressed the progression of renal scarring, at least in part, via inhibition of activated TGF-beta/Smad signaling.
引用
收藏
页码:63 / 74
页数:12
相关论文
共 34 条
[21]  
Miyazono K, 2000, J CELL SCI, V113, P1101
[22]  
Morath C, 2001, J AM SOC NEPHROL, V12, P2300, DOI 10.1681/ASN.V12112300
[23]   Enalapril decreases nuclear factor kappa B activation in the kidney with ureteral obstruction [J].
Morrissey, JJ ;
Klahr, S .
KIDNEY INTERNATIONAL, 1997, 52 (04) :926-933
[24]   Regulation of Smad7 promoter by direct association with Smad3 and Smad4 [J].
Nagarajan, RP ;
Zhang, JM ;
Li, W ;
Chen, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (47) :33412-33418
[25]  
Ostendorf T, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133658
[26]   Pathophysiology of progressive nephropathies [J].
Remuzzi, G ;
Bertani, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (20) :1448-1456
[27]   Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice [J].
Sharma, K ;
Jin, YL ;
Guo, J ;
Ziyadeh, FN .
DIABETES, 1996, 45 (04) :522-530
[28]   THE EMERGING ROLE OF TRANSFORMING GROWTH-FACTOR-BETA IN KIDNEY-DISEASES [J].
SHARMA, K ;
ZIYADEH, FN .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (06) :F829-F842
[29]   Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor β-induced Smad-dependent transcriptional activation [J].
Stroschein, SL ;
Wang, W ;
Luo, KX .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (14) :9431-9441
[30]   Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor β [J].
von Gersdorff, G ;
Susztak, K ;
Rezvani, F ;
Bitzer, M ;
Liang, D ;
Böttinger, EP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (15) :11320-11326